Sonrai Analytics key facts
as of Oct 2026- Developer of analytics software designed to elevate data, discover new treatments, or expedite research development.
- Sonrai Analytics is valued at approximately $15.1M as of Oct 2026 (last reported valuation).
- It has raised $6.3M; the latest was PE Growth/Expansion in Sep 2025.
- Notable investors include Innovate UK, Molten Ventures, Techstart Ventures, Clarendon Fund Managers, Invest Northern Ireland — 9 tracked in total.
- Status: Privately Held (backing).
Sonrai Analytics's last reported valuation, Apr 2025. Nothing priced has surfaced since.
- ·Watch Sonrai Analytics: the Monday email on marks, rounds and moves
Sonrai Analytics funding rounds
No funding rounds for Sonrai Analytics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Sonrai Analytics valuation
Sonrai Analytics's last reported valuation was $15.1 million in Apr 2025. No priced round, secondary trade or fund mark has surfaced since.
Sonrai Analytics investors
9 investors are on record for Sonrai Analytics, including Innovate UK, Molten Ventures, Techstart Ventures and Clarendon Fund Managers.
About Sonrai Analytics
Developer of analytics software designed to elevate data, discover new treatments, or expedite research development. The company's software integrates multi-omic data, advanced AI analytics, and a secure infrastructure for accelerated drug candidate identification and biomarker discovery, enabling precision medicine organizations to streamline research, reduce time-to-market, and improve patient outcomes.
- Sector
- Information Technology
- HQ
- Belfast, United Kingdom
- Founded
- 2018
- Employees
- 39
- Website
- sonraianalytics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.